Catching Up: Convergence, #NEINNO, What's Next in Tech
- The sixth edition of Convergence: The Life Sciences Leaders Forum (an event I help organize) happened last week. Oddly, attendance was up from 2008. Not sure how to explain that. Featured speakers included Genzyme CEO Henri Termeer, Sirtris founder Christoph Westphal, Harvard Pilgrim CEO Charlie Baker, Beth Israel CEO Paul Levy, and cutting edge researchers David Altshuler from the Broad and David Eisenberg from Harvard. Xconomy had some coverage, as did Mass High Tech, and there was a pretty healthy stream of tweets, too.
(Termeer's appearance was followed by a great Sunday Globe story by Stephen Heuser, and then some unfortunate company news on Tuesday, as Genzyme was forced to shut down its Allston plant for decontamination.)
For the first time, we're sharing audio from the event. You can either download the MP3s for later listening, or just click play.
- Christoph Westphal / Henri Termeer session on "The Past, Present & Future of Genzyme." (MP3 file.)
- Alnylam CEO John Maraganore moderates a panel of executives from GlaxoSmithKline, Biogen Idec, Novartis, and Merck on "The New Logic of Partnerships, Licensing Deals, and Collaborations." (MP3 file.)
- Stromedix CEO Michael Gilman talks to David Altshuler of the Broad Institute and David Eisenberg of Harvard Medical School's Osher Research Center about their research. (MP3 file.)
- Jeffrey Krasner interviews Beth Israel Deaconess CEO Paul Levy and Harvard Pilgrim CEO Charlie Baker about the future of the healthcare system. (MP3 file.)
- I've been psyched to see how many people have been tweeting about New England Innovation Month using the tag #neinno. This coming week wraps things up, so do help spread the word -- and try to get out to an event. (We just added a free event called PitchPub to the calendar.)
- For my part, I'll be dropping by XSITE 2009 and EurekaFest on Wednesday and Friday, and moderating/emceeing things at What's Next in Tech on Thursday evening -- which looks like it is attracting a great group of participants (listed on the registration page all the way at the bottom.)
- I'm also adding the Social Media Breakfast series to the list of regular gatherings (at right)... although I find it impossible to figure out from their site when the next one will be held (!)
(In the photo is Genzyme CEO Henri Termeer being interviewed by Sirtris Pharmaceuticals founder Christoph Westphal, at Convergence 2009.)
Labels: Alnylam, Charlie Baker, Convergence Forum, David Altshuler, David Eisenberg, Genzyme, John Maraganore, June is Innovation Month in New England, Michael Gilman, Paul Levy, Sirtris Pharma, whatsnext09